Between 2013 and 2023, the import values of Blood, Antisera, Vaccines, Toxins, and Cultures to the UAE exhibited significant fluctuations. The actual import value stood at $702.63 million in 2023. After a dip in 2017, there was a substantial recovery, with 2018 seeing a dramatic increase of 176.19%. The average Compound Annual Growth Rate (CAGR) over five years from 2013 to 2018 was 15.9%. The trend between 2019 and 2023 displayed more stability, with the year-on-year growth varying modestly and ending with a relatively slow CAGR of 0.36% over the last five years. Looking ahead, the forecasted CAGR from 2024 to 2028 is projected to be 2.32%, indicating a steady yet moderate growth trajectory for the future.
Future trends to watch for include technological advancements in vaccine development, potential regulatory changes, and shifts in global healthcare priorities, which could impact import quantities and values. Additionally, evolving disease patterns and vaccination programs will likely influence future import demands for these medical supplies in the UAE.
